ALK expands digital venture with US partnership

Allergy firm ALK has established a new collaboration in New York to persuade more US allergy patients to buy tablets from ALK.

ALK CEO Carsten Hellmann | Photo: Gregers Tycho/Ritzau/Ritzau Scanpix

After having struggled for some time to gain footing with tablet vaccines for allergy treatments on the US market, ALK has started considering alternative sales channels.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs